Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of IMP3 by EGFR signaling and repression by ERβ: implications for triple-negative breast cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 44, Pages 4689-4697
Publisher
Springer Nature
Online
2012-01-24
DOI
10.1038/onc.2011.620
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IMP3, a New Biomarker to Predict Progression of Cervical Intraepithelial Neoplasia Into Invasive Cancer
- (2011) Di Lu et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- RNA-binding Protein Insulin-like Growth Factor mRNA-binding Protein 3 (IMP-3) Promotes Cell Survival via Insulin-like Growth Factor II Signaling after Ionizing Radiation
- (2011) Baisong Liao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidermal Growth Factor Receptor-mediated Tissue Transglutaminase Overexpression Couples Acquired Tumor Necrosis Factor-related Apoptosis-inducing Ligand Resistance and Migration through c-FLIP and MMP-9 Proteins in Lung Cancer Cells
- (2011) Zi Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2
- (2011) Ramaswamy Suvasini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP
- (2010) Markus Hafner et al. CELL
- Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancer
- (2010) Pingdong Li et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
- (2010) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells
- (2010) X T Zhang et al. ONCOGENE
- Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells
- (2010) L Xu et al. ONCOGENE
- Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib
- (2010) Giulia Pinton et al. PLoS One
- EGFR signaling in breast cancer: Bad to the bone
- (2010) John Foley et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Oncofetal Protein IMP3
- (2009) Wenxin Zheng et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis
- (2009) Dawei Li et al. ANNALS OF SURGICAL ONCOLOGY
- IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype
- (2009) Otto Walter et al. HUMAN PATHOLOGY
- Estrogen receptor-β expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2009) Jonathan D Marotti et al. MODERN PATHOLOGY
- What is triple-negative breast cancer?
- (2008) William J. Irvin et al. EUROPEAN JOURNAL OF CANCER
- Basal carcinoma of the breast revisited: an old entity with new interpretations
- (2008) E Korsching et al. JOURNAL OF CLINICAL PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started